Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.82 USD | -2.54% | +10.92% | +662.09% |
Jun. 03 | Corbus Pharmaceuticals Reaches 2-Year High After Drug Results | DJ |
Jun. 03 | Oppenheimer Adjusts Corbus Pharmaceuticals Price Target to $80 From $60, Maintains Outperform Rating | MT |
- Stock Market
- Equities
- CRBP Stock
- News Corbus Pharmaceuticals Holdings, Inc.
- MarketScreener Editorial Features